Research Projects & Grants

For Profit Organization

  • CSB-C20-003: A Multi-Center. Randomized, Double-Masked, Vehicle-Controlled. Parallel-Group. Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1 % in stage 2 and 3 Neurotrophic Keratitis Subjects, Role: PI, Claris Biotherapeutics, (12/2022 - 12/2023) Status: Approved


  • The effects of call on dry eye symptoms as measured by the Schirmer Test, Role: PI, LLU Dept. of Ophthalmology, (07/2013 - 07/2014) Status: Completed